Neuroone Medical Technologies (NMTC) Capital Expenditures (2019 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Capital Expenditures came in at $38516.0 in Q1 2026, up 1114.63% YoY from $3171.0 in Q1 2025, and down 5.49% on a QoQ basis from $40754.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Capital Expenditures (2019 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 8 years of Capital Expenditures data on file, last reported at $38516.0 in Q1 2026.
- Quarterly Capital Expenditures rose 1114.63% year-over-year to $38516.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133425.0 (up 68.27% YoY) and the FY2025 annual result came in at $81742.0, down 31.99% from the prior year.
- Capital Expenditures retreated to $38516.0 in Q1 2026, from $40754.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $175694.0 in Q1 2023 to a low of $3171.0 in Q1 2025.
- A 5-year average of $51709.5 and a median of $38516.0 in 2026 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2025 — Capital Expenditures tumbled 89.89% — and 2026, when it jumped 1114.63%.
- Tracing NMTC's Capital Expenditures over 5 years: stood at $11512.0 in 2022, then soared by 222.54% to $37131.0 in 2023, then sank by 34.24% to $24416.0 in 2024, then soared by 66.92% to $40754.0 in 2025, then declined by 5.49% to $38516.0 in 2026.
- The last three Capital Expenditures figures came in at $38516.0 (Q1 2026), $40754.0 (Q4 2025), and $10607.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Neuroone Medical Technologies | 19.64 Mn | 17.59 Mn | 1.18 Mn | 19,659.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19,659.00 |
| Jun 30, 2026 | 19,659.00 |
| Mar 31, 2026 | 38,516.00 |
| Mar 31, 2026 | 38,516.00 |
| Dec 31, 2025 | 40,754.00 |
| Dec 31, 2025 | 40,754.00 |
| Sep 30, 2025 | 10,607.00 |
| Sep 30, 2025 | 10,607.00 |
| Jun 30, 2025 | 43,548.00 |
| Jun 30, 2025 | 43,548.00 |
| Mar 31, 2025 | 3,171.00 |
| Mar 31, 2025 | 3,171.00 |
| Dec 31, 2024 | 24,416.00 |
| Dec 31, 2024 | 24,416.00 |
| Sep 30, 2024 | 36,905.00 |
| Sep 30, 2024 | 36,905.00 |
| Jun 30, 2024 | 14,801.00 |
| Jun 30, 2024 | 14,801.00 |
| Mar 31, 2024 | 31,360.00 |
| Mar 31, 2024 | 31,360.00 |